Trypanosoma cruzi DNA and proteins — Drug Target
All drugs that target Trypanosoma cruzi DNA and proteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- Short treatment with benznidazole · Laboratorio Elea Phoenix S.A. · Nitroimidazole antiparasitic · Infectious Disease / Parasitology
Benznidazole is a nitroimidazole antiparasitic that generates reactive metabolites to damage the DNA and proteins of Trypanosoma cruzi, the parasite causing Chagas disease.